Top Dupixent Manufacturers: Who’s Leading the Market?
Are you on the hunt for the best Dupixent manufacturers but feeling overwhelmed by the options? You’re not alone! With so many factories claiming to provide top-notch quality, it’s tough to know who to trust. Finding the right supplier is crucial—not just for quality assurance but also for cost efficiency and reliability. The right manufacturer can make all the difference in your production timeline and product satisfaction. Imagine partnering with a factory that meets your standards and exceeds your expectations.
This can lead to better patient outcomes and more successful treatments. Ready to discover the top 30 Dupixent manufacturers that stand out in quality and service? Keep reading to find the perfect match for your needs!
Top 30 Dupixent Manufacturer Manufacturers
Dupixent – Biologic Treatment for Chronic Conditions
Domain: dupixent.com
Registered: 2015 ( 10 years )
Introduction: DUPIXENT® (dupilumab) is a prescription medication approved for the treatment of multiple conditions including moderate-to-severe eczema, asthma, chronic obstructive pulmonary disease, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, chronic spontaneous urticaria, and bullous pemphigoid.
Dupixent – Monoclonal Antibody for Inflammatory Conditions
Domain: dupixenthcp.com
Registered: 2016 ( 9 years )
Introduction: Dupixent (dupilumab) is a monoclonal antibody used to treat various inflammatory conditions, including asthma, eczema, and chronic rhinosinusitis with nasal polyps.
Regeneron – Monoclonal Antibody Treatments
Domain: investor.regeneron.com
Registered: 1997 ( 28 years )
Introduction: Dupixent® (dupilumab) is a fully human monoclonal antibody approved for the treatment of bullous pemphigoid (BP) in adults, targeting underlying type 2 inflammation.
Sanofi Market Access – Dupixent for Type 2 Inflammation
Domain: sanofimarketaccess.com
Registered: 2023 ( 2 years )
Introduction: DUPIXENT (dupilumab) is the only treatment approved in 7 indications driven in part by type 2 inflammation.
Sanofi – Chronic Inflammatory Condition Treatments
Domain: sanofi.us
Registered: 2002 ( 23 years )
Introduction: Dupixent is a prescription medication developed by Sanofi for the treatment of various chronic inflammatory conditions such as asthma, eczema, and chronic rhinosinusitis with nasal polyps.
Sanofi – Dupixent for Bullous Pemphigoid Treatment
Domain: sanofi.com
Registered: 1995 ( 30 years )
Introduction: Dupixent (dupilumab) is an injection approved for the treatment of adult patients with bullous pemphigoid (BP) and is the only targeted medicine for this condition.
Pharmaceutical Technology – Dupixent for Allergic Conditions
Domain: pharmaceutical-technology.com
Registered: 2000 ( 25 years )
Introduction: Dupixent is a monoclonal antibody used for the treatment of various allergic and inflammatory conditions.
Wellwisp – Allergy and Inflammation Treatment Solutions
Domain: wellwisp.com
Registered: 2023 ( 2 years )
Introduction: Dupixent is a monoclonal antibody used to treat various allergic and inflammatory conditions such as asthma, eczema, and chronic rhinosinusitis with nasal polyps.
Manufacturing – Innovative Inflammatory Condition Treatments
Domain: manufacturing.reviewtekno.com
Registered: 2019 ( 6 years )
Introduction: Dupixent is a groundbreaking medication that treats various inflammatory conditions, manufactured by Sanofi and Regeneron Pharmaceuticals.
Kersten Compliance – Atopic Dermatitis Treatment Solutions
Domain: kerstencompliance.com
Registered: 2019 ( 6 years )
Introduction: DUPIXENT is an interleukin-4 receptor alpha antagonist indicated for the treatment of adult patients with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
Fierce Pharma – Allergy Treatment Solutions
Domain: fiercepharma.com
Registered: 2007 ( 18 years )
Introduction: Dupixent is a medication developed by Sanofi and Regeneron, approved for treating chronic spontaneous urticaria (hives) among other conditions.
Dupixent MyWay – Personalized Case Management Services
Domain: dupixentmywayportal.com
Registered: 2018 ( 7 years )
Introduction: Information not available.
Drugs.com – Dupixent for Bullous Pemphigoid Treatment
Domain: drugs.com
Registered: 1998 ( 27 years )
Introduction: Dupixent (dupilumab) is a targeted medicine approved for the treatment of bullous pemphigoid (BP) in the U.S.
Pro – Chronic Inflammatory Condition Treatments
Domain: pro.campus.sanofi
Registered: 2021 ( 4 years )
Introduction: Dupixent is a prescription medication used to treat certain chronic inflammatory conditions such as asthma, eczema, and chronic rhinosinusitis with nasal polyps.
Pharmiweb – Dupixent for Bullous Pemphigoid Treatment
Domain: pharmiweb.com
Registered: 1998 ( 27 years )
Introduction: Dupixent (dupilumab) is an injection approved in the US for the treatment of adult patients with bullous pemphigoid (BP), a chronic skin disease characterized by intense itch and painful blisters.
Pharmaphorum – Allergy and Inflammation Treatment Insights
Domain: pharmaphorum.com
Registered: 2009 ( 16 years )
Introduction: Dupixent is a medication developed by Sanofi, indicated for the treatment of various allergic and inflammatory conditions.
Cpmckservice – Dupixent for Chronic Inflammatory Conditions
Domain: cpmckservice.dupixent.com
Registered: 2015 ( 10 years )
Introduction: Dupixent is a prescription medication used to treat certain chronic inflammatory conditions such as asthma, eczema, and chronic rhinosinusitis with nasal polyps.
Menafn – Dupixent for Bullous Pemphigoid Treatment
Domain: menafn.com
Registered: 2000 ( 25 years )
Introduction: Dupixent (dupilumab) is approved in the U.S. as the only targeted medicine to treat adult patients with bullous pemphigoid (BP), a chronic skin disease characterized by intense itch and painful blisters.
PalmettoPharm – Allergy and Inflammation Treatments
Domain: palmettopharm.com
Registered: 2022 ( 3 years )
Introduction: Dupixent is a prescription medication used to treat various allergic and inflammatory conditions.
Dhpp – Inflammatory Condition Treatment Solutions
Domain: dhpp.hpfb-dgpsa.ca
Registered: 2020 ( 5 years )
Introduction: DUPIXENT is a prescription medication used to treat various inflammatory conditions such as asthma, eczema, and chronic rhinosinusitis with nasal polyps.
Mims – Dupixent for Atopic Dermatitis and Asthma
Domain: mims.com
Registered: 1995 ( 30 years )
Introduction: Dupixent is a prescription medication used to treat certain conditions such as moderate to severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps.
Nasdaq – Dupixent for Chronic Skin Conditions
Domain: nasdaq.com
Registered: 1993 ( 32 years )
Introduction: Dupixent® (dupilumab) is approved for treating adults with bullous pemphigoid, a chronic skin disease characterized by intense itching and blisters.
Healthcareradius – Dupixent for Atopic Dermatitis
Domain: healthcareradius.in
Registered: 2013 ( 12 years )
Introduction: Dupixent (dupilumab) is a biologic medicine approved for the treatment of adults with atopic dermatitis in India.
Accessdata – Dupixent Injection for Chronic Conditions
Domain: accessdata.fda.gov
Registered: 2000 ( 25 years )
Introduction: DUPIXENT (dupilumab) injection, for subcutaneous use, is indicated for the treatment of various conditions including atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyposis, eosinophilic esophagitis, and prurigo nodularis.
Medical News Today – Dupixent Treatment Information
Domain: medicalnewstoday.com
Registered: 2003 ( 22 years )
Introduction: Dupixent is a prescription medication used to treat various conditions such as asthma, eczema, and chronic rhinosinusitis with nasal polyps.
Pharmacompass – Dupixent API and Formulations
Domain: pharmacompass.com
Registered: 2014 ( 11 years )
Introduction: Dupixent is an active pharmaceutical ingredient (API) with multiple suppliers and various finished dosage formulations (FDFs) available in different regions.
Biospace – COPD Biologic Solutions
Domain: biospace.com
Registered: 1995 ( 30 years )
Introduction: Dupixent is the first-ever biologic medicine approved in the US for patients with Chronic Obstructive Pulmonary Disease (COPD).
Sanofi Canada – Dupixent for Eosinophilic Esophagitis
Domain: sanoficanada.mediaroom.com
Registered: 2001 ( 24 years )
Introduction: DUPIXENT® (dupilumab injection) is a fully human monoclonal antibody approved for the treatment of eosinophilic esophagitis (EoE) in patients aged 12 years and older, weighing at least 40 kg. It is the first biologic therapy approved for EoE in Canada.
Morningstar – Healthcare Solutions
Domain: morningstar.com
Registered: 1989 ( 36 years )
Introduction: Dupixent is an anti-inflammatory drug developed by Regeneron Pharmaceuticals and marketed jointly with Sanofi. It has received FDA approval for use as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease (COPD).
Yahoo Finance – Allergy and Asthma Treatments
Domain: finance.yahoo.com
Registered: 1995 ( 30 years )
Introduction: Dupixent (dupilumab) is a monoclonal antibody approved for the treatment of various allergic conditions and asthma.
Category Information
The keyword “Dupixent manufacturer” refers to the pharmaceutical company responsible for producing Dupixent, a medication used primarily to treat various chronic inflammatory conditions such as asthma, eczema, and chronic rhinosinusitis with nasal polyps. The manufacturer of Dupixent is Regeneron Pharmaceuticals, in partnership with Sanofi. This collaboration highlights the significant role of biopharmaceutical companies in developing targeted therapies that address complex medical needs. The category of pharmaceutical manufacturers encompasses organizations that research, develop, and produce medications for various health conditions.
These manufacturers are crucial in advancing medical science and improving patient outcomes by providing innovative treatments. Understanding the manufacturer behind specific drugs like Dupixent is important for healthcare professionals and patients alike, as it can impact drug availability, safety, efficacy, and pricing in the healthcare market.
Application Information
Dupixent, manufactured by Sanofi and Regeneron, is primarily utilized in the healthcare sector, particularly for managing chronic inflammatory conditions. One of its key application areas is in dermatology, where it is commonly prescribed for moderate to severe eczema, providing significant relief to patients suffering from this condition. Another important application is in the field of pulmonology, where Dupixent is used to treat asthma, especially in patients with eosinophilic asthma.
Its ability to target specific pathways in the immune response makes it beneficial for those who do not respond well to traditional therapies. Additionally, Dupixent is employed in the treatment of chronic rhinosinusitis with nasal polyps, improving the quality of life for patients by reducing inflammation and symptoms associated with this condition. Overall, Dupixent serves a crucial role in managing chronic diseases across multiple medical disciplines.
Production Process Information
The production of Dupixent, a medication used to treat various allergic conditions and asthma, involves several key stages. First, research and development is crucial. Scientists work to understand the underlying biology of the conditions Dupixent treats and develop the drug through extensive testing in laboratories and clinical trials to ensure its safety and effectiveness. Once the drug is approved, the next stage is manufacturing. This involves producing the active ingredients in controlled environments, ensuring quality and consistency.
After production, the drug undergoes quality control testing to confirm that it meets all regulatory standards before packaging. Finally, the distribution phase ensures that Dupixent is delivered to pharmacies and healthcare providers. Throughout this process, compliance with regulations and maintaining safety standards are vital to ensure that patients receive effective and safe medication.
Frequently Asked Questions (FAQs)
What should I consider when choosing a Dupixent manufacturer?
When selecting a Dupixent manufacturer, consider their regulatory compliance, quality control processes, production capacity, and experience with biologics. Ensure they have certifications like GMP (Good Manufacturing Practices) and a solid track record in producing similar medications. Additionally, assess their ability to meet your specific needs regarding volume and delivery timelines.
How can I verify a manufacturer’s credentials?
To verify a manufacturer’s credentials, request documentation of their certifications, such as GMP and ISO standards. You can also check their reputation through industry references, customer reviews, and any regulatory inspections they have undergone. Engaging with third-party auditors for assessments can provide further assurance of their compliance and quality standards.
What is the importance of quality control in Dupixent manufacturing?
Quality control is crucial in Dupixent manufacturing to ensure the safety, efficacy, and consistency of the medication. It involves rigorous testing and monitoring throughout the production process to detect any potential issues early. A manufacturer with strong quality control measures minimizes risks and helps maintain compliance with regulatory requirements.
How can I find potential Dupixent manufacturers?
You can find potential Dupixent manufacturers through industry trade shows, online directories, and pharmaceutical networking platforms. Additionally, reaching out to industry associations or consulting with sourcing agents can help you identify reputable manufacturers. Don’t forget to leverage your professional network for recommendations!
What are the common pitfalls to avoid when selecting a manufacturer?
Common pitfalls include overlooking regulatory compliance, neglecting to visit the facility, and failing to ask for references. Avoid rushing the selection process; take the time to evaluate multiple manufacturers thoroughly. Also, ensure clear communication regarding your needs and expectations to prevent misunderstandings down the line.